共 124 条
[1]
Akin R.(1998)Evaluation of bone mineral density in children receiving antiepileptic drugs Pediatr. Neurol. 19 129-131
[2]
Okutan V.(2012)May long term oxcarbazepine treatment be lead to secondary hyperparathyroidism J. Clin. Neurol. 8 65-68
[3]
Sarici U.(2006)Adverse effects of antiepileptic drugs on bone mineral density Pediatr. Neurol. 35 177-181
[4]
Babacan O.(1997)Vitamin D, calcium, and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status Am. J. Clin. Nutr. 65 1042-1051
[5]
Karaoglu A.(2000)The cost of epilepsy in the United States: an estimate from population-based clinical and survey data Epilepsia 41 342-351
[6]
Vurucu S.(2007)Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet Epilepsia 48 66-71
[7]
Babayigit A.(2007)Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways Drug Metab. Dispos. 35 1032-1041
[8]
Dirik E.(1994)Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children Brain Dev. 16 382-385
[9]
Bober E.(1970)Osteomalacia with long-term anticonvulsant therapy in epilepsy Br. Med. J. 4 69-72
[10]
Baer M.T.(2013)Bone mineral density in children with long-term antiepileptic therapy Srp. Arh. Celok. Lek. 141 329-332